此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Epidemiology, Treatment and Prognosis of Neonatal Meningitis in Turkey: A Multicenter Study (NEO-MENINGITIS)

2019年7月6日 更新者:Mehmet Yekta Oncel、Zekai Tahir Burak Women's Health Research and Education Hospital

Zekai Tahir Burak Women's Health Research and Education Hospital

Meningitis, defined as inflammation of the meninges caused by different pathogens, is a serious infection associated with high morbidity and mortality. It occurs more commonly in the neonatal period than in any other age group. Neonatal meningitis is a devastating infection that occurs more commonly in neonates than in any other age group, and is associated with significant morbidity and mortality. In this study, we aimed to evaluate epidemiology, treatment and prognosis of neonatal meningitis in a large-scale retrospective multicenter cohort study.

The main objectives of this study were to assess the incidence, temporal trend, risk factors, causative organisms, and short term outcomes of neonatal meningitis in a large national cohort of newborn infants admitted to Turkey NICUs.

研究概览

地位

未知

研究类型

观察性的

注册 (预期的)

500

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Ankara、火鸡
        • 招聘中
        • Zekai Tahir Burak Women's Health Research and Education Hospital
        • 接触:
      • Bursa、火鸡
        • 招聘中
        • Bursa Yuksek Ihtisas Research and Education Hospital
        • 接触:
      • Diyarbakır、火鸡
        • 招聘中
        • Gazi Yasargil Education Research Hospital
        • 接触:
      • İstanbul、火鸡
        • 招聘中
        • Istanbul Kanuni Sultan Suleyman Training and Research Hospital
        • 接触:
      • İzmir、火鸡、35590
        • 招聘中
        • Izmir Katip Celebi University, Medical Faculty
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

不超过 4周 (孩子)

接受健康志愿者

有资格学习的性别

全部

取样方法

非概率样本

研究人群

In this study,

  1. Lumbar puncture performed due to suspected meningitis and
  2. CSF laboratory findings are consistent with meningitis and
  3. Positivity in CSF culture and/or CSF PCR
  4. Neonates hospitalized between 1 January 2014 and 31 May 2019 will be included in the study.

    • The list of all cases diagnosed as on Neonatal Meningitis with growth in CSF culture and / or causative agent by CSF PCR will be obtained from the hospital's database.
    • Term infants will be included in the study until 1 month and preterm infants will be adjusted until the first month.

描述

Inclusion Criteria:

  • Subject has a positive cerebrospinal fluid culture/PCR of bacterial pathogen.
  • Subject has a positive blood culture of bacterial pathogen and counts of white blood cells in cerebrospinal fluid ≥20 /mm3.

Exclusion Criteria:

  • Major congenital anomalies
  • Cultures positive for coagulase-negative staphylococci (CONS) were excluded as possible contaminants, if not clinically and laboratory compatible with meningitis.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of neonatal meningitis
大体时间:average of 5 years
Occurrence of a meningitis in NICU within a specified period of time. (Number of neonatal meningitis cases / Total number of inpatients in the study period)
average of 5 years

次要结果测量

结果测量
措施说明
大体时间
Causative organisms
大体时间:average of 5 years
Number and types of isolated microorganisms in CSF cultures
average of 5 years
Neurodevelopmental Outcome
大体时间:18 to 24 months
- Bayley Scales of Infant Development, Second Edition (BSID II), was performed a comprehensive assessment including neurological and developmental evaluation. The mean BSID II score is 100 for Mental Developmental Index (MDI) and Psychomotor Developmental Index (PDI), with a standard deviation (SD) of 15; a score of less than 70 (42 SDs below the mean) indicates a significant delay. Infants who were so severely impaired that testing with the BSID II could not be performed were assigned a MDI and PDI score of 49.
18 to 24 months
Mortality
大体时间:up to 28 days
Neonatal meningitis related mortality
up to 28 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Mehmet Yekta Oncel, M.D.、Tepecik Training and Research Hospital

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2019年6月1日

初级完成 (预期的)

2019年10月1日

研究完成 (预期的)

2019年10月1日

研究注册日期

首次提交

2019年7月2日

首先提交符合 QC 标准的

2019年7月3日

首次发布 (实际的)

2019年7月5日

研究记录更新

最后更新发布 (实际的)

2019年7月9日

上次提交的符合 QC 标准的更新

2019年7月6日

最后验证

2019年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • Tepecik35

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅